{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:58:27Z","timestamp":1794711507728,"version":"4.9.1"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>\u03b2-Elemene, a natural compound extracted from over 50 different Chinese medicinal herbs and plants, has been effective in the treatment of hyperplastic and proliferative disorders such as prostatic hypertrophy, hysteromyoma and neoplasms. Our previous studies have demonstrated that \u03b2-elemene exhibits strong inhibitory activity in ovarian cancer cells. The aim of the present study was to assess the effect of \u03b2-elemene on prostate cancer cells as well as other types of tumour cells and to determine whether the effect of \u03b2-elemene on prostate cancer cell death was mediated through the induction of apoptosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The MTT assay was used to evaluate the ability of \u03b2-elemene to inhibit cellular proliferation in cancer cells. Cellular apoptosis was assessed by annexin V binding, TUNEL and ELISA-based assays. Caspase activity was measured using a caspases assay kit. The protein levels of Bcl-2, caspases, cytochrome c and poly(ADP-ribose) polymerase (PARP) were analysed by Western blotting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>Here, we showed that \u03b2-elemene had an antiproliferative effect on androgen-insensitive prostate carcinoma DU145 and PC-3 cells. Treatment with \u03b2-elemene also inhibited the growth of brain, breast, cervical, colon and lung carcinoma cells. The effect of \u03b2-elemene on cancer cells was dose dependent, with IC50 values ranging from 47 to 95 \u00b5g\/ml (230\u2013465 \u00b5m). TUNEL assay and flow cytometric analysis using annxin V\/propidium iodide staining revealed that the percentage of apoptotic prostate cancer cells was increased by \u03b2-elemene in a dose- and time-dependent manner. Moreover, \u03b2-elemene exposure resulted in a decreased Bcl-2 protein level, increased cytochrome c release, and activated PARP and caspase-3, -7, -9, and -10 in prostate cancer cells.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Overall, these findings suggest that \u03b2-elemene exerts broad-spectrum antitumour activity against many types of solid carcinoma and supports a proposal of \u03b2-elemene as a new potentially therapeutic drug for castration-resistant prostate cancer and other solid tumours.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.2042-7158.2010.01135.x","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T17:58:44Z","timestamp":1279735124000},"page":"1018-1027","source":"Crossref","is-referenced-by-count":87,"title":["Antineoplastic effect of <i>\u03b2<\/i>-elemene on prostate cancer cells and other types of solid tumour cells"],"prefix":"10.1093","volume":"62","author":[{"given":"Qingdi Quentin","family":"Li","sequence":"first","affiliation":[{"name":"School of Medicine, West Virginia University Health Sciences Center , Morgantown, West Virginia,","place":["USA"]},{"name":"National Institutes of Health , Bethesda, Maryland,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangduo","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Medicine, West Virginia University Health Sciences Center , Morgantown, West Virginia,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Medicine, West Virginia University Health Sciences Center , Morgantown, West Virginia,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malathi","family":"Banda","sequence":"additional","affiliation":[{"name":"School of Medicine, West Virginia University Health Sciences Center , Morgantown, West Virginia,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddie","family":"Reed","sequence":"additional","affiliation":[{"name":"School of Medicine, West Virginia University Health Sciences Center , Morgantown, West Virginia,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,8,1]]},"reference":[{"key":"2024103013101025700_cit1","volume-title":"United States Cancer Statistics: 1999\u20132005 Incidence and Mortality Web-based Report","author":"US Cancer Statistics Working Group","year":"2009"},{"key":"2024103013101025700_cit2","first-page":"391","article-title":"The role of androgen in the regulation of programmed cell death\/apoptosis in normal and malignant prostatic tissue","volume":"5","author":"Isaacs","year":"1994","journal-title":"Semin Cancer Biol"},{"key":"2024103013101025700_cit3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1464-410X.1997.d01-6840.x","article-title":"The Medical Research Council Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial","volume":"79","year":"1997","journal-title":"Br J Urol"},{"key":"2024103013101025700_cit4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-0-387-69080-3_21","article-title":"Castration-recurrent prostate cancer is not androgen-independent","volume":"617","author":"Mohler","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"2024103013101025700_cit5","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2217\/fon.09.117","article-title":"Molecular mechanisms of castration-resistant prostate cancer progression","volume":"5","author":"Dutt","year":"2009","journal-title":"Future Oncol"},{"key":"2024103013101025700_cit6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.urolonc.2009.03.016","article-title":"Castration-resistant prostate cancer: targeting androgen metabolic pathways in recurrent disease","volume":"27","author":"Mostaghel","year":"2009","journal-title":"Urol Oncol"},{"key":"2024103013101025700_cit7","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/1078-0432.CCR-08-1171","article-title":"Castration-resistant prostate cancer: locking up the molecular escape routes","volume":"15","author":"Attar","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2024103013101025700_cit8","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.eururo.2009.06.027","article-title":"Castration-resistant prostate cancer: from new pathophysiology to new treatment targets","volume":"56","author":"Chi","year":"2009","journal-title":"Eur Urol"},{"key":"2024103013101025700_cit9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0090-4295(02)01593-5","article-title":"Androgen receptor as a target in androgen-independent prostate cancer","volume":"60","author":"Balk","year":"2002","journal-title":"Urology"},{"key":"2024103013101025700_cit10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0002-9440(10)63112-4","article-title":"Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance","volume":"164","author":"Holzbeierlein","year":"2004","journal-title":"Am J Pathol"},{"key":"2024103013101025700_cit11","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1158\/0008-5472.CAN-08-0249","article-title":"Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth","volume":"68","author":"Montgomery","year":"2008","journal-title":"Cancer Res"},{"key":"2024103013101025700_cit12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0959-8049(09)70029-2","article-title":"Chemotherapy in patients with castration-resistant prostate cancer","volume":"45","author":"Meulenbeld","year":"2009","journal-title":"Eur J Cancer"},{"key":"2024103013101025700_cit13","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1101\/gad.819500","article-title":"Molecular genetics of prostate cancer","volume":"14","author":"Abate-Shen","year":"2000","journal-title":"Genes Dev"},{"key":"2024103013101025700_cit14","first-page":"23","article-title":"Apoptosis in prostate cancer: progressive and therapeutic implications (Review)","volume":"14","author":"Wang","year":"2004","journal-title":"Int J Mol Med"},{"key":"2024103013101025700_cit15","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1101\/gad.12.11.1551","article-title":"Proteases to die for","volume":"12","author":"Cryns","year":"1998","journal-title":"Genes Dev"},{"key":"2024103013101025700_cit16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","article-title":"Apoptosis: a link between cancer genetics and chemotherapy","volume":"108","author":"Johnstone","year":"2002","journal-title":"Cell"},{"key":"2024103013101025700_cit17","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.1074721","article-title":"Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization","volume":"297","author":"Lassus","year":"2002","journal-title":"Science"},{"key":"2024103013101025700_cit18","first-page":"1758","article-title":"Fas-mediated apoptosis in human prostatic carcinoma cell lines","volume":"57","author":"Rokhlin","year":"1997","journal-title":"Cancer Res"},{"key":"2024103013101025700_cit19","volume-title":"\u03b2-Elemene method to prepare the same and use thereof","author":"Chen","year":"2002"},{"key":"2024103013101025700_cit20","volume-title":"Elemene compositions containing liquid oil","author":"Chen","year":"2005"},{"key":"2024103013101025700_cit21","volume-title":"Synthesis of \u03b2-elemene intermediates thereto, analogues and uses thereof","author":"Huang","year":"2006"},{"key":"2024103013101025700_cit22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/(SICI)1097-4644(1997)27+<106::AID-JCB17>3.0.CO;2-L","article-title":"Initial study on naturally occurring products from traditional Chinese herbs and vegetables for chemoprevention","volume":"27","author":"Zheng","year":"1997","journal-title":"J Cell Biochem"},{"key":"2024103013101025700_cit23","first-page":"959","article-title":"Experimental study on apoptosis induced by elemene in glioma cells","volume":"22","author":"Zhou","year":"2003","journal-title":"Ai Zheng"},{"key":"2024103013101025700_cit24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00018-005-5017-3","article-title":"Antitumor effect of \u03b2-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death","volume":"62","author":"Wang","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"2024103013101025700_cit25","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s00018-005-5027-1","article-title":"Antiproliferative effect of \u03b2-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase","volume":"62","author":"Li","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"2024103013101025700_cit26","first-page":"241","article-title":"In vitro combination characterization of the new anticancer plant drug b-elemene with taxanes against human lung carcinoma","volume":"31","author":"Zhao","year":"2007","journal-title":"Int J Oncol"},{"key":"2024103013101025700_cit27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3892\/or_00000420","article-title":"\u03b2-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis","volume":"22","author":"Li","year":"2009","journal-title":"Oncol Rep"},{"key":"2024103013101025700_cit28","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1211\/jpp.61.12.0010","article-title":"An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas","volume":"61","author":"Wu","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"2024103013101025700_cit29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0092-8674(94)90518-5","article-title":"Apoptosis in cancer therapy: crossing the threshold","volume":"78","author":"Fisher","year":"1994","journal-title":"Cell"},{"key":"2024103013101025700_cit30","doi-asserted-by":"crossref","first-page":"45737","DOI":"10.1074\/jbc.M300574200","article-title":"Epidermal growth factor receptor-dependent, NF-kB-independent activation of the phosphatidylinositol 3-kinase\/Akt pathway inhibits ultraviolet irradiation-induced caspases-3, -8, and -9 in human keratinocytes","volume":"278","author":"Wang","year":"2003","journal-title":"J Biol Chem"},{"key":"2024103013101025700_cit31","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1158\/0008-5472.CAN-03-1675","article-title":"Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells","volume":"64","author":"Kim","year":"2004","journal-title":"Cancer Res"},{"key":"2024103013101025700_cit32","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1177\/44.9.8773561","article-title":"In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations","volume":"44","author":"Negoescu","year":"1996","journal-title":"J Histochem Cytochem"},{"key":"2024103013101025700_cit33","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1126\/science.281.5381.1312","article-title":"Caspases: enemies within","volume":"281","author":"Thornberry","year":"1998","journal-title":"Science"},{"key":"2024103013101025700_cit34","doi-asserted-by":"crossref","first-page":"11549","DOI":"10.1074\/jbc.274.17.11549","article-title":"An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9","volume":"274","author":"Zou","year":"1999","journal-title":"J Biol Chem"},{"key":"2024103013101025700_cit35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1211\/jpp.60.2.0001","article-title":"Ellagic acid, pomegranate and prostate cancer \u2013 a mini review","volume":"60","author":"Bell","year":"2008","journal-title":"J Pharm Pharmacol"},{"key":"2024103013101025700_cit36","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1089\/jmf.2004.7.274","article-title":"Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells","volume":"7","author":"Albrecht","year":"2004","journal-title":"J Med Food"},{"key":"2024103013101025700_cit37","doi-asserted-by":"crossref","first-page":"14813","DOI":"10.1073\/pnas.0505870102","article-title":"Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer","volume":"102","author":"Malik","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024103013101025700_cit38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4161\/cc.5.4.2486","article-title":"Prostate cancer prevention through pomegranate fruit","volume":"5","author":"Malik","year":"2006","journal-title":"Cell Cycle"},{"key":"2024103013101025700_cit39","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1517\/13543784.15.10.1191","article-title":"Clinical trials of natural products as chemopreventive agents for prostate cancer","volume":"15","author":"Bemis","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"2024103013101025700_cit40","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.juro.2006.07.004","article-title":"Chemoprevention for bladder cancer","volume":"176","author":"Busby","year":"2006","journal-title":"J Urol"},{"key":"2024103013101025700_cit41","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.2741\/2233","article-title":"Green tea polyphenols in the prevention of colon cancer","volume":"12","author":"Kumar","year":"2007","journal-title":"Front Biosci"},{"key":"2024103013101025700_cit42","first-page":"1633","article-title":"The Chinese medicinal herbal formula ZYD88 inhibits cell growth and promotes cell apoptosis in prostatic tumor cells","volume":"10","author":"Zhu","year":"2003","journal-title":"Oncol Rep"},{"key":"2024103013101025700_cit43","first-page":"111","article-title":"Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer","volume":"37","author":"Liang","year":"2010","journal-title":"Int J Oncol"},{"key":"2024103013101025700_cit44","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0092-8674(94)90518-5","article-title":"Apoptosis in cancer therapy: crossing the threshold","volume":"78","author":"Fisher","year":"1994","journal-title":"Cell"},{"key":"2024103013101025700_cit45","doi-asserted-by":"crossref","first-page":"38830","DOI":"10.1074\/jbc.M103632200","article-title":"PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression","volume":"276","author":"Huang","year":"2001","journal-title":"J Biol Chem"},{"key":"2024103013101025700_cit46","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/1097-0142(20000915)89:6<1329::AID-CNCR19>3.0.CO;2-Q","article-title":"Novel strategies and therapeutics for the treatment of prostate carcinoma","volume":"89","author":"Morris","year":"2000","journal-title":"Cancer"},{"key":"2024103013101025700_cit47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/A:1020875925685","article-title":"Prostate cancer gene therapy: past experiences and future promise","volume":"21","author":"Gardner","year":"2002","journal-title":"Cancer Metastasis Rev"},{"key":"2024103013101025700_cit48","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1073\/pnas.97.13.7124","article-title":"Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells","volume":"97","author":"Wang","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024103013101025700_cit49","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0002-9440(10)64779-7","article-title":"Mechanisms of apoptosis","volume":"157","author":"Reed","year":"2000","journal-title":"Am J Pathol"},{"key":"2024103013101025700_cit50","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1101\/gad.13.15.1899","article-title":"BCL-2 family members and the mitochondria in apoptosis","volume":"13","author":"Gross","year":"1999","journal-title":"Genes Dev"},{"key":"2024103013101025700_cit51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/pros.20167","article-title":"Apigenin drives the production of reactive oxygen species and initiates a mitochondrial mediated cell death pathway in prostate epithelial cells","volume":"63","author":"Morrissey","year":"2005","journal-title":"Prostate"},{"key":"2024103013101025700_cit52","first-page":"2175","article-title":"Antisense RNA down-regulation of bcl-xL expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents","volume":"62","author":"Vilenchik","year":"2002","journal-title":"Cancer Res"},{"key":"2024103013101025700_cit53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1021692801278","article-title":"BCL-2 in prostate cancer: a minireview","volume":"8","author":"Catz","year":"2003","journal-title":"Apoptosis"},{"key":"2024103013101025700_cit54","first-page":"6940","article-title":"Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer","volume":"52","author":"McDonnell","year":"1992","journal-title":"Cancer Res"},{"key":"2024103013101025700_cit55","first-page":"5594","article-title":"Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line","volume":"56","author":"McConkey","year":"1996","journal-title":"Cancer Res"},{"key":"2024103013101025700_cit56","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0090-4295(98)00360-4","article-title":"bcl-2\/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer","volume":"52","author":"Mackey","year":"1998","journal-title":"Urology"},{"key":"2024103013101025700_cit57","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/cncr.11230","article-title":"Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x","volume":"97","author":"Pollack","year":"2003","journal-title":"Cancer"},{"key":"2024103013101025700_cit58","doi-asserted-by":"crossref","first-page":"17941","DOI":"10.1074\/jbc.274.25.17941","article-title":"Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation","volume":"274","author":"Saleh","year":"1999","journal-title":"J Biol Chem"},{"key":"2024103013101025700_cit59","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0955-0674(02)00381-2","article-title":"Apoptosomes: engines for caspase activation","volume":"14","author":"Adams","year":"2002","journal-title":"Curr Opin Cell Biol"},{"key":"2024103013101025700_cit60","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis","volume":"407","author":"Hengartner","year":"2000","journal-title":"Nature"},{"key":"2024103013101025700_cit61","first-page":"1605","article-title":"Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease","volume":"57","author":"Krajewska","year":"1997","journal-title":"Cancer Res"},{"key":"2024103013101025700_cit62","first-page":"4713","article-title":"Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand\/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11","volume":"63","author":"Ray","year":"2003","journal-title":"Cancer Res"},{"key":"2024103013101025700_cit63","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0248-4900(00)01109-6","article-title":"The mediating role of caspase-3 protease in the intracellular mechanism of genistein-induced apoptosis in human prostatic carcinoma cell lines, DU145 and LNCaP","volume":"92","author":"Kumi-Diaka","year":"2000","journal-title":"Biol Cell"},{"key":"2024103013101025700_cit64","first-page":"382","article-title":"Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: overexpression of caspase-7 as a new gene therapy strategy for prostate cancer","volume":"59","author":"Marcelli","year":"1999","journal-title":"Cancer Res"},{"key":"2024103013101025700_cit65","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/1097-0142(20011101)92:9<2297::AID-CNCR1576>3.0.CO;2-B","article-title":"Priming prostate carcinoma cells for increased apoptosis is associated with up-regulation of the caspases","volume":"92","author":"Coffey","year":"2001","journal-title":"Cancer"},{"key":"2024103013101025700_cit66","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1139\/o97-043","article-title":"Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death","volume":"75","author":"Duriez","year":"1997","journal-title":"Biochem Cell Biol"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2042-7158.2010.01135.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/62\/8\/1018\/60233446\/j.2042-7158.2010.01135.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/62\/8\/1018\/60233446\/j.2042-7158.2010.01135.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T18:44:00Z","timestamp":1730313840000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/62\/8\/1018\/6135644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,1]]},"references-count":66,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,8,1]]},"published-print":{"date-parts":[[2010,8,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.2042-7158.2010.01135.x","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,8]]},"published":{"date-parts":[[2010,8,1]]}}}